Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 96NIH 7NETWORK 3OTHER_GOV 2INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Thoracic 1Plasma cell 1Other solid neoplasm 1Gastrointestinal 1

Conditions

Breast Neoplasms 107Neoplasms 70Colorectal Neoplasms 51Uterine Cervical Neoplasms 41Prostatic Neoplasms 32Stomach Neoplasms 31Motor Activity 26Carcinoma, Hepatocellular 24Lung Neoplasms 22Rectal Neoplasms 21Colonic Neoplasms 19Head and Neck Neoplasms 18Pancreatic Neoplasms 17Brain Neoplasms 15Pain 14Polycystic Ovary Syndrome 13Recurrence 12Pain, Postoperative 11Lymphoma 11Esophageal Neoplasms 11Anxiety Disorders 11Ovarian Neoplasms 10Glioma 10Endometrial Neoplasms 10Thyroid Neoplasms 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Pilonidal Sinus 9Carcinoma, Non-Small-Cell Lung 9Papillomavirus Infections 8Hematologic Neoplasms 8

Interventions

COVID-19 Serological Testing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × OTHER_GOV × Leukemia, Lymphocytic, Chronic, B-Cell × Clear all
NCT06971848 2026-03-30

ETCABIO

University Hospital, Angers

Phase NA Not yet recruiting
70 enrolled
GastrointestinalLymphoidOther hematologic neoplasmOther solid neoplasmPlasma cellThoracic

Immunoglobulin Light-chain Amyloidosis, Esophageal Squamous Cell Carcinoma, Mesothelioma, Malignant, Carcinoma, Bronchogenic, Heart Neoplasms, Carcinoma, Hepatocellular, Lymphoma, Follicular, Colorectal Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Cholangiocarcinoma, Neoplasms, Plasma Cell

NCT04862806 2021-09-17

Safety, Efficacy of BNT162b2 mRNA Vaccine in CLL

Bnai Zion Medical Center

Phase NA Unknown
1,000 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡